NCT05326087View on ClinicalTrials.gov

Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2027

Conditions
Preimplantation Genetic TestingProgestin-primed Ovarian StimulationPolycystic Ovarian SyndromeGnRH Antagonist
Interventions
DRUG

GnRH antagonist

GnRH antagonist (Cetrorelix 0.25mg) once subcutaneously daily from day 6 of ovarian stimulation till the day of the ovulation trigger

DRUG

MPA

oral MPA 10mg qd from Day 3 of ovarian stimulation till the day of ovulation trigger.

All Listed Sponsors
lead

ShangHai Ji Ai Genetics & IVF Institute

OTHER